Stay updated on Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial

Sign up to get notified when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The Revision label on the Record History page now shows v3.6.2 instead of v3.6.0, indicating a newer build of the page. The update updates the page's version indicator without changing the study details or history entries.
    Difference
    0.1%
    Check dated 2026-06-27T01:06:19.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The Study Record Versions area now shows additional metadata labels—Last verified and Last known status was—and includes a new revision marker (Revision: v3.6.0), indicating an updated page version and verification metadata.
    Difference
    3%
    Check dated 2026-06-12T15:54:53.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A new Revision label, v3.5.5, replaces the previous v3.5.4, indicating a new build of the page; this update reflects an internal version change rather than alterations to trial information.
    Difference
    0.1%
    Check dated 2026-06-05T10:42:00.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new revision label (Revision: v3.5.4) was added to the record history, and the previous label (Revision: v3.5.3) was removed.
    Difference
    0.1%
    Check dated 2026-05-15T05:17:06.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision history shows a new page version, from v3.5.2 to v3.5.3, indicating a minor update to the record's metadata.
    Difference
    0.1%
    Check dated 2026-04-30T16:46:33.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 in the study record history.
    Difference
    0.1%
    Check dated 2026-04-16T10:36:16.000Z thumbnail image

Stay in the know with updates to Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.